Sermorelin
- Category
- Growth Hormone
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
A synthetic fragment of GHRH that prompts the pituitary to release growth hormone, marketed for anti-aging, body composition, and sleep. It reliably raises GH, but the anti-aging benefits rest on weak human evidence; the strongest data is in pediatric growth. Injection-site reactions hit roughly 1 in 6, hypothyroidism and fluid retention can occur, and long-term anti-aging safety is unstudied. Supplied through compounding pharmacies and banned by WADA.
Read Full recordStudied uses & evidence
Studied uses(7)
Natural GH stimulation
HighHuman trials show pulsatile GH release; one adult sermorelin trial doubled mean 24-hour GH and raised IGF-1 by about 34%.
Body composition
LowFat loss and lean gains seen mainly with a related molecule, not sermorelin directly.
Cognitive function
MediumHuman trials report better executive function and overall cognition in older adults.
Evidence limits
- Evidence Level
- Limited Clinical
Strongest evidence concerns pediatric GH deficiency. Adult evidence is limited and molecule-specific: a sermorelin cognition trial had 89 completers, while the 152-person cognition trial used tesamorelin. Studies of modified GHRH analogues should be identified separately.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Active cancer
HighGH stimulation via GHRH pathway may promote tumor growth.
Pituitary damage
HighRequires functional pituitary to produce GH. Ineffective with pituitary damage.
Diabetic retinopathy
HighGH/IGF-1 elevation can worsen proliferative retinopathy.
Risk summary(5)
Risks = level of concern: High · Moderate · Low · Theoretical
Injection site reactions (~1 in 6 patients)
HighHypothyroidism observed in 6.5% of clinical study patients
ModeratePotential GH-related effects: water retention, joint pain
ModerateLarge-scale long-term safety data for off-label anti-aging use lacking
HighWADA banned for competitive athletes
High
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.